Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

CompletedOBSERVATIONAL
Enrollment

46

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

June 10, 2024

Study Completion Date

June 10, 2024

Conditions
Systemic Lupus Erythematosus
Interventions
OTHER

None (Observational study)

Not applicable since this is observational study.

Trial Locations (15)

Unknown

Research Site, Brest

Research Site, Caen

Research Site, Dijon

Research Site, Lille

Research Site, Paris

Research Site, Toulouse

Research Site, Athens

Research Site, Ramat Gan

Research Site, Tel Aviv

Research Site, Pisa -PI-

Research Site, Porto

Research Site, Barcelona

Research Site, Coslada, Madrid

Research Site, Valladolid

Research Site, Leeds

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

CernerEnviza / Oracle

UNKNOWN

lead

AstraZeneca

INDUSTRY